IOA-244(p110δ PI3K) Stops Breast Tumor Progression Mono/Combo Tx
Episode Summary
IOA-244, a selective PI3Kδ inhibitor, shows potential to slow breast cancer by targeting tumor cells and microenvironment, offering safer therapy and biomarker-guided combination strategies.